Tag: ILMN

  • Early Morning Vibes: 4 Solid Stocks for Wednesday Trading Session

    Early Morning Vibes: 4 Solid Stocks for Wednesday Trading Session

    Good Morning

    On December 22, the American stock indexes finished trading in different directions. The S&P 500 dropped by 0.21% to 3687 points, the Dow Jones fell at a rate of 0.67%, while the NASDAQ climbed at 0.51%. Consumer confidence was significantly worse than expected. The tech sector became the leader of growth with a result of 0.86%; Apple shares acted as the engine, rising in price by 2.85%. The communications sector was one of the outsiders, losing 0.99%.
     

    Corporate Highlights

    Peloton Interactive (PTON: + 11.7%) buys exercise equipment manufacturer Precor for $ 420 million to increase production capacity.
     

    Revenue and EPS CarMax (KMX: -8.1%) were better than expected, but profit margins fell, and demand weakened at the end of the quarter due to COVID-19.

    Sports goods retailer Sportsman’s Warehouse Holdings (SPWH: + 39.6%) will be acquired by the Great American Outdoors Group.
     

    Today, world stock exchanges are showing mostly positive dynamics. The focus of attention is the unexpected statement by Donald Trump about his intention to change the parameters of the economic aid package, for which Congressmen voted yesterday. The current president believes that the one-time payment to the population should be increased from $ 600 per person to $ 2,000. Joseph Biden also noted that it is necessary to expand stimulus measures. Additional cash payments to the population should be included in the next package of assistance to the economy. Most likely, Trump will still sign the bill in the coming days.
     

    New strains of coronavirus continue to cause concern for investors, although virology experts believe that the vaccines available today are effective against the mutated COVID-19. Representatives of AstraZeneca and BioNTech agree.

    Nevertheless, full-fledged research has not yet been carried out. There is no complete confidence in this issue. In general, the news background is close to neutral, but the publication of the macrostatistics block may shift the balance in one direction or another.
     

    Economic Highlights
     

    Today there are weekly data on the number of initial applications for unemployment benefits. The indicator is expected to remain at the level of the previous week – 885

    thousand. If the actual value turns out to be above 893 thousand, it will become the highest since August. The labor market situation remains challenging. More than 5.5 million Americans are currently receiving unemployment benefits.

    Also, the indicator of the expenses of individuals for November will be published. Against the backdrop of new quarantine restrictions, consumption is expected to decrease.
     

    By 0.2% compared to October levels, which will be the first negative value since April. A month earlier, expenses increased by 0.5%.

    Today Top Movers

    ‎‎‎Hexo Corp (HEXO)‎‎ share price gaining 300.00% at $4.08 in early morning trading session today following its declaration of lapse of base shelf prospectus.‎‎ ‎

    ‎‎‎Ocugen, Inc (OCGN)‎‎ increasing 83.81% at $1.48 during premarket trading on Wednesday after the company and Bharat Biotech declared the signing of binding letter of intent (LOI) to co-develop Bharat Biotech’s COVID-19 vaccine candidate, COVAXIN, for the United States market.‎‎ ‎

    ‎‎‎Jaguar Health Inc (JAGX)‎‎ is up 52.85% at $0.61 in today’s premarket trading session after declaring the voting results of Jaguar’s December 9, 2020 in the Special Meeting of Stockholders.‎‎ ‎

    ‎‎‎Onconova Therapeutics Inc (ONTX)‎‎ share price changing with the gain of 38.76% at $0.59 in premarket trading on Wednesday after announcing FDA Permission for study to proceed under its investigational new drug application for Multi-kinase CDK4/6 Inhibitor ON 123300.

    Top Upgrades & Downgrades


    Truist Securities turned bullish on Pioneer Natural Resources Company (PXD), upgrading the stock to “Buy” and assigning a $135.0 price target.
     

    Rent-A-Center Inc. (RCII) has won the favor of Loop Capital’s equity research team. The firm upgraded the shares from Hold to Buy and moved their price target to $50.
     

    Illumina Inc. (ILMN) received an upgrade from analysts at Piper Sandler, who also set their one-year price target on the stock to $415.0. They changed their rating on ILMN to Overweight from Neutral in a recently issued research note.
     

    Earlier Wednesday BMO Capital reduced its rating on Fubotv Inc (NYSE: FUBO) stock to Market Perform from Outperform and assigned the price target to $50.
     

    Canaccord Genuity analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Paysign Inc (NASDAQ: PAYS) has been changed to Hold from Buy and the new price target is set at $5.
     

    Analysts at BMO Capital downgraded IAC/Interactivecorp (NASDAQ: IAC)’s stock to Market Perform from Outperform on Wednesday.

    Latest Insider Activity


    FireEye Inc. (FEYE) EVP and General Counsel King Alexa announced the sale of shares taking place on Dec 21 at $20.03 for some 56,532 shares. The total came to more than $1.13 million.
     

    Apartment Investment and Management Company (AIV) Director STEIN MICHAEL A sold on Dec 21 a total 0 shares at $4.70 on average. The insider’s sale generated proceeds of almost $0.22 million.
     

    GameStop Corp. (GME) 10% Owner Cohen Ryan declared the purchase of shares taking place on Dec 18 at $15.97 for some 756,089 shares. The transaction amount was around $12.08 million.
     

    Upstart Holdings Inc. (UPST) 10% Owner Loeb Daniel S bought on Dec 18 a total 13,381,222 shares at $20.00 on average. The purchase cost the insider an estimated $24.0 million.

    Earnings To Watch


    Top US earnings releases scheduled for today include Paychex Inc. (NASDAQ:PAYX). It will announce its Nov 2020 financial results. The company is expected to report earnings of $0.66 per share from revenues of $954M in the three-month period.
     

    Analysts expect Bridgeline Digital Inc. (NASDAQ:BLIN) to report a net income (adjusted) of $0.03 per share, when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Sep 2020 is predicted to come in at $2.64M.

  • 15 Trending Stocks To Watch In Diagnostics And Research Industry

    15 Trending Stocks To Watch In Diagnostics And Research Industry

    The Diagnostic Research Industry is playing an integral part in the medical evaluation and treatment of patients.  This industry is vital to the healthcare market as it is providing information related to the severity and causes of illnesses in patients to healthcare practitioners. The changes we are witnessing in today’s healthcare industry are setting the goal for evolution we will see over the next decade.

    There are major drivers that are changing and will change the direction of this industry in present and future as well. The first driver is technology. As time passes by, new technologies are emerging and playing a very important role in the healthcare industry. In today’s world, patients want easier access to care and demand better service. The demand for this industry is linked to the number of patients receiving the treatment. The profitability and growth of the company depend on good marketing and efficient operations.

    Let check these 15 companies in Diagnostic Research Industry to know more about this industry and the trends this industry is following:

    Interpace Biosciences Inc. (NASDAQ: IDXG)

    Interpace Biosciences Inc. (NASDAQ: IDXG) shares were trading up 32.89% at $3.96 at the time of writing on Wednesday. Interpace Biosciences Inc. (NASDAQ: IDXG) share price went from a low point around $2.57 to briefly over $11.00 in the past 52 weeks, though shares have since pulled back to $3.96. IDXG market cap has remained high, hitting $15.88M at the time of writing, giving it a price-to-sales ratio of more than 0.

    Interpace Biosciences Inc. (NASDAQ: IDXG) has announced that the Audit Committee has disclosed the result of an independent investigation. The committee has completed the investigation with the statement that the allegations made in the complaints were unverified and there is no truth behind them. investigation and If we look at the recent analyst rating IDXG, Janney initiated coverage on IDXG shares with a Buy rating.

    OPKO Health Inc. (NASDAQ: OPK)

    OPKO Health Inc. (NASDAQ: OPK) last closed at $4.07, in a 52-week range of $1.12 to $6.47. Analysts have a consensus price target of $8.00. OPKO Health Inc. (OPK) disclosed it plans to report operating and financial results for the three months ended September 30, 2020, as well as discuss financial guidance, after the close of the U.S. financial markets on Thursday, October 29, 2020.

    Invitae Corporation (NYSE: NVTA)

    Invitae Corporation (NYSE: NVTA) stock drop by -6.29% to $49.28. The most recent rating by JP Morgan, on October 14, 2020, is at a Neutral. Invitae Corporation (NVTA) disclosed that on October 2, 2020, it has executed the transaction to bring ArcherDX into Invitae to create a comprehensive offering that provides testing services for disease risk, therapy optimization, and personalized cancer monitoring to enable precision approaches to cancer treatment.

    Pacific Biosciences of California Inc. (NASDAQ: PACB)

    Pacific Biosciences of California Inc. (NASDAQ: PACB) shares headed rising, higher as much as 0.07%. The most recent rating by JP Morgan, on October 02, 2020, is at an Overweight. Pacific Biosciences of California Inc. (PACB) has disclosed that collaborated with Children’s Mercy Kansas City to further understand the most challenging pediatric diseases. The companies will join forces to sequence a statistically significant cohort of rare disease cases for which previous whole-genome and whole-exome sequencing studies yielded no answers.

    Bionano Genomics Inc. (NASDAQ: BNGO)

    Bionano Genomics Inc. (NASDAQ: BNGO) fall -0.15% after losing more than $0.0 on Wednesday. Bionano Genomics Inc. (BNGO) revealed today that it is scheduled to release financial results of the third quarter ended September  30, 2020, on November 12, 2020. The company will also hold the conference call on the same day.

    T2 Biosystems Inc. (NASDAQ: TTOO)

    T2 Biosystems Inc. (NASDAQ: TTOO) stock drop by 0.00% to $1.33 after T2 Biosystems to Report Third Quarter 2020 Financial Results on November 4, 2020. The most recent rating by BTIG Research, on October 08, 2020, is at a Buy.  T2 Biosystems Inc. (TTOO) market capitalization has remained high, hitting $196.79 million at the time of writing.

    NeoGenomics Inc. (NASDAQ: NEO)

    NeoGenomics Inc. (NASDAQ: NEO) Shares headed rising, higher as much as 5.46%. The most recent rating by Morgan Stanley, on September 09, 2020, is at an Overweight. NeoGenomics Inc. (NEO) revealed its plans to open a state-of-the-art research laboratory in China in association with the new lab PPD, Inc. (NASDAQ: PPD) is opening in Suzhou.

    PerkinElmer Inc. (NYSE: PKI)

    PerkinElmer Inc. (NYSE: PKI) fall -2.10% after losing more than -$2.62 on Wednesday. PerkinElmer Inc. (PKI) earlier announced that it is expected to report organic revenue growth of approximately 35% and 33%, respectively, for the third quarter ended October 4, 2020.

    Chembio Diagnostics Inc. (NASDAQ: CEMI)

    Chembio Diagnostics Inc. (NASDAQ: CEMI) last closed at $4.77, in a 52-week range of $2.25 to $15.89. Analysts have a consensus price target of $5.00. Chembio Diagnostics Inc. (CEMI) disclosed earlier that the U.S. Food and Drug Administration (FDA) has approved the Premarket Approval (PMA) application for the DPP HIV-Syphilis System.

    Illumina Inc. (NASDAQ: ILMN)

    Illumina Inc. (NASDAQ: ILMN) Shares headed falling, lower as much as -4.35%. The most recent rating by Guggenheim, on October 13, 2020, is at a Neutral. Illumina Inc. (ILMN) has earlier announced that it is scheduled to release the third quarter 2020 following the close of the market on Thursday, October 29, 2020.

    Enzo Biochem Inc. (NYSE: ENZ)

    Enzo Biochem Inc. (NYSE: ENZ) fall -17.24% after losing more than -$0.45 on Wednesday. Enzo Biochem Inc. (ENZ) earlier reported financial results for the fourth quarter and full-year ended July 31, 2020, and provided a business update on recent corporate and operational developments.

    Fulgent Genetics Inc. (NASDAQ: FLGT)

    Fulgent Genetics Inc. (NASDAQ: FLGT) last closed at $38.17, in a 52-week range of $6.70 to $52.47. Analysts have a consensus price target of $56.25. Fulgent Genetics Inc. (FLGT) disclosed earlier that the Ohio Department of Rehabilitation and Correction (“ODRC”) has selected Fulgent Genetics for their COVID-19 testing needs.

    QIAGEN N.V. (NYSE: QGEN)

    QIAGEN N.V. (NYSE: QGEN) stock drop by -0.11% to $52.37. The most recent rating by BofA Securities, on October 06, 2020, is at a Buy. QIAGEN N.V. (QGEN) earlier announced preliminary sales and adjusted earnings per share (EPS) results for the third quarter of 2020. It has shared that the Net sales grew 26% at actual rates, and also rose 26% at constant exchange rates (CER) $481.3 million from $382.7 million in the same period of 2019.

    Fluidigm Corporation (NASDAQ: FLDM)

    Fluidigm Corporation (NASDAQ: FLDM) last closed at $6.89, in a 52-week range of $1.17 to $12.45. Fluidigm Corporation (FLDM) has moved up 488.03% from its 52-weeks low and moved down -44.74% from its 52-weeks high. Looking at its liquidity, it has a current ratio of $509.65 million at the time of writing.

    Danaher Corporation (NYSE: DHR)

    Danaher Corporation (NYSE: DHR) stock soar by 0.41% to $226.55. The most recent rating by Wolfe Research, on June 16, 2020, is at an Outperform. Danaher Corporation (DHR) share price went from a low point around $119.60 to briefly over $227.48 in the past 52 weeks, though shares have since pulled back to $222.59. DHR  market cap has remained high, hitting $156.91 billion at the time of writing.

     

     

  • 10 Of The Best Diagnostics Research Industry Stocks To Buy For 2020

    10 Of The Best Diagnostics Research Industry Stocks To Buy For 2020

    Healthcare is a dynamic and opportunity-rich industry. The demand for innovations that brings improvement in health outcomes, affordability, quality, and access will continue to be high. The changes we witnessed in the healthcare industry today have set a new tone for the change in the coming few years. 2020 is the year of change for the health care industry.

    The first thing which played an important role in the healthcare industry is Technology. Technology is continuously changing and brings new improvement in the healthcare industry. Patients today want easier and affordable access to care and better demand services. In this changing environment, diagnostics is emerging as a key driver in helping to address these needs.

    Here are the top 10 leading companies in Diagnostics Research Industry that need your attention:

    OPKO Health Inc. (NASDAQ: OPK)

    OPKO Health Inc. (NASDAQ: OPK) shares were trading down -0.92% at $3.22 at the time of writing on Tuesday. OPKO Health Inc. (NASDAQ: OPK) share price went from a low point around $1.12 to briefly over $6.47 in the past 52 weeks, though shares have since pulled back to $3.22. OPK market cap has remained high, hitting $2.13B at the time of writing, giving it a price-to-sales ratio of more than 2.

    OPKO Health Inc. has earlier started a Phase 2 trial with RAYALDEE as a treatment for mild-to-moderate COVID-19.  If we look at the recent analyst rating OPK, Piper Jaffray initiated coverage on OPK shares with an Overweight rating.

    Pacific Biosciences of California Inc. (NASDAQ: PACB)

    Pacific Biosciences of California Inc. (NASDAQ: PACB) last closed at $8.78, in a 52-week range of $2.20 to $8.38. Analysts have a consensus price target of $6.50. Pacific Biosciences of California Inc. (PACB) has announced it has appointed Susan G. Kim as Chief Financial Officer. The decision is effective as of September 28, 2020. Susan has joined the company at a time when there are various growth opportunities for the company.

    Bionano Genomics Inc. (NASDAQ: BNGO)

    Bionano Genomics Inc. (NASDAQ: BNGO) stock soar by 0.79% to $0.64. The most recent rating by Oppenheimer, on April 08, 2020, is at an Outperform. Bionano Genomics Inc. (BNGO) will participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. the summit is scheduled to take place virtually on September 21-23, 2020. This company market capitalization has remained high, hitting $90.45 million at the time of writing.

    Illumina Inc. (NASDAQ: ILMN)

    Illumina Inc. (NASDAQ: ILMN) shares headed falling, lower as much as -0.60%. The most recent rating by UBS, on September 22, 2020, is at a Neutral. Illumina Inc. (ILMN) has officially revealed an agreement to buy cancer-testing company Grail for about $8 billion in cash and stock. This company market capitalization has remained high, hitting $39.54 billion at the time of writing.

    Precipio Inc. (NASDAQ: PRPO)

    Precipio Inc. (NASDAQ: PRPO) shares headed rising, higher as much as 2.63%. Precipio Inc. has revealed that it has introduced its HemeScreen AML (Acute Myeloid Leukemia) panel both clinically in its CLIA laboratory, and as part of its HemeScreen product offering. This company market capitalization has remained high, hitting 37.42 million at the time of writing.

    Fulgent Genetics Inc. (NASDAQ: FLGT)

    Fulgent Genetics Inc. (NASDAQ: FLGT) stock soar by 7.08% to $40.25. The most recent rating by Oppenheimer, on August 20, 2020, is at an Outperform. Fulgent Genetics Inc. (FLGT) will replace Garrett Motion Inc. (GTX) in the S&P SmallCap 600 effective before the opening of trading on Friday, September 25. This company’s market capitalization has remained high, hitting $821.10 million at the time of writing.

    Fluidigm Corporation (NASDAQ: FLDM)

    Fluidigm Corporation (NASDAQ: FLDM) fall -1.29% after losing more than -$0.11 on Tuesday. In the past 52-weeks of trading, this company’s stock fluctuated between the low range of $1.17 and a high range of $12.45. It has moved up 595.73% from its 52-weeks low and moved down -34.62% from its 52-weeks high. Looking at its liquidity it has a current ratio of 2.00. This company’s market capitalization has remained high, hitting $523.91 million at the time of writing.

    Invitae Corporation (NYSE: NVTA)

    Invitae Corporation (NYSE: NVTA) last closed at $43.10, in a 52-week range of $7.41 to $40.96. Analysts have a consensus price target of $36.25. Invitae Corporation (NVTA) has moved up 475.19% from its 52-weeks low and moved down -2.16% from its 52-weeks high. Looking at its liquidity it has a current ratio of 3.70. This company’s market capitalization has remained high, hitting $5.56 billion at the time of writing.

    HTG Molecular Diagnostics Inc. (NASDAQ: HTGM)

    HTG Molecular Diagnostics Inc. (NASDAQ: HTGM) fall -8.01% after losing more than -$0.03 on Tuesday. HTG Molecular Diagnostics Inc. (HTGM) share price went from a low point around $0.27 to briefly over $0.99 in the past 52 weeks, though shares have since pulled back to $0.32. HTG Molecular Diagnostics Inc. market cap has remained high, hitting $22.70 million at the time of writing

    Co-Diagnostics Inc. (NASDAQ: CODX)

    Co-Diagnostics Inc. (NASDAQ: CODX) last closed at $14.93, in a 52-week range of $0.85 to $30.99. Co-Diagnostics Inc. (CODX) has moved up 1567.08% from its 52-weeks low and moved down -54.47% from its 52-weeks high. Looking at its liquidity it has a current ratio of 11.60. This company’s market capitalization has remained high, hitting $404.90 million at the time of writing.